Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02832154 · ClinicalTrials.gov registry record · NA
Internet-Delivered Positive Affect Program in Managing Emotion in Young Adult Cancer Survivors
A NA study of Cancer Survivor, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 2
- Study locations
NCT02832154: Completed NA study of Cancer Survivor, sponsored by Wake Forest University Health Sciences.
NCT02832154 is a NA study of Cancer Survivor that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 43 participants, below the 265-participant average among 25 other Cancer Survivor trials with a reported enrollment target (84% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02832154, a NA study of Cancer Survivor, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 2
- Study locations
Study Summary
This pilot clinical trial studies how well an internet-delivered positive affect (PA) intervention works in managing emotion in young adult cancer survivors. An internet-delivered PA intervention may teach younger cancer survivors healthy coping skills and help doctors to learn more about what effects mood may have on the health and well-being of young adults with cancer.
Primary Outcome
Quantitative measures and interview will be used to quantify acceptability. The mean of participants responding affirmatively to the highest two responses from an intervention evaluation phone interview script created by investigators will be combined and exact 95% confidence intervals (CIs) will be calculated for these estimates. Participants were asked the following questions: On a scale of 0 to 10, with 0 being definitely not to 10 being definitely yes, to what extent would you recommend thes
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Internet-Based Intervention
- PROCEDURE Quality-of-Life Assessment
Study Locations (2)
Illinois
- Northwestern University - Chicago
North Carolina
- Comprehensive Cancer Center of Wake Forest University - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2017-04-21 |
| Est. Completion | 2020-04-23 |
| Phase | NA |
What the finished NCT02832154 record still lists
NCT02832154 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 265-participant average among 25 other Cancer Survivor trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Cancer Survivor appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT02832154 reports a single indexed study location in Illinois, North Carolina.
Frequently Asked Questions
What is clinical trial NCT02832154 about?
NCT02832154 is a clinical study titled "Internet-Delivered Positive Affect Program in Managing Emotion in Young Adult Cancer Survivors". This pilot clinical trial studies how well an internet-delivered positive affect (PA) intervention works in managing emotion in young adult cancer survivors. An internet-delivered PA intervention may teach younger cancer survivors healthy coping skills and help doctors to learn more about what effec...
What is the current status of trial NCT02832154?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2017-04-21. Estimated completion is 2020-04-23.
What conditions does trial NCT02832154 study?
This clinical trial studies the following conditions: Cancer Survivor.
What interventions are being tested in trial NCT02832154?
The interventions under investigation include: Questionnaire Administration (OTHER), Internet-Based Intervention (OTHER), Quality-of-Life Assessment (PROCEDURE).
Who is sponsoring clinical trial NCT02832154?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02832154 being conducted?
This trial has 2 study locations across Illinois, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Survivor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02832154's enrollment target sits among peer trials
43 20th of 25 higher than 6 of 25 other Cancer Survivor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer Survivor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Leading Healthy Eating and Activity Promotion Program
RECRUITING · NA
-
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors
RECRUITING · NA
-
An Acupuncture Study for Cancer Survivors With Joint Pain
RECRUITING · NA
-
Text -Based Depression Screening Among Cancer Survivors
RECRUITING · NA
-
Making Healthy Habits Stick
RECRUITING · NA
-
Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI